Seeking Alpha
Research analyst, growth at reasonable price, newsletter provider, Top 300 fund picks
Profile| Send Message|
( followers)  

Many leading funds filed forms 13-D and 13-G (and form 4) with the SEC on Friday, including Fairfax Financial Holdings, Massachusetts Financial Services and JPMorgan Chase & Co., indicating that they had amended their ownership in U.S. traded public companies. Also, we have included, when applicable, SEC Form 4 filings by Institutions that are considered corporate insiders by virtue of their holding more than 10% ownership, and in many cases having representation on the Board of Directors. The following are the most notable filings on Friday (for more info on Forms 13-D and 13-G, and how to interpret that, please refer to the end of this article):

Research in Motion Ltd. (RIMM): RIMM is a Canadian manufacturer of Blackberry handheld devices for the mobile communications market. On Friday, Toronto-based Fairfax Financial Holdings, headed by legendary investors Prem Watsa (often called the "Canadian Warren Buffet", and with over $2 billion in 13-F assets per their latest Q3 filing, filed SEC Form SC13G indicating that it holds a passive investment stake of 26.8 million or 5.1% of outstanding shares, an increase of 15.0 million shares from the 11.8 million shares it reported at the end of Q3. The stock has had a strong rebound recently from the $12.45 low in December, mostly on renewed takeover speculation; however, in an interview with CrackBerry, the new CEO suggested that he was adamantly against breaking up or selling the company. Mr. Watsa has a reputation of profiting by betting against the Wall Street herd mentality, which in this case has been bearish on RIMM. The stock currently trades at 5-6 forward P/E and 0.8 P/B compared to averages of 30.4 and 3.2 for the wireless equipment group, while earnings are projected to fall going forward from $6.34 in 2011 to $2.93 in 2013.

St. Jude Medical (NYSE:STJ): STJ develops cardiovascular medical devices for cardiac rhythm management, atrial fibrillation, cardiac surgery, cardiology and neuromodulation. On Friday, Boston-based Massachusetts Financial Services, with over $80 billion in 13-F assets per their latest Q3 filing, filed SEC Form SC 13G/A indicating that it holds a passive investment stake of 25.4 million or 8.0% of outstanding shares, an increase of 6.1 million shares from the 19.3 million shares it held at the end of Q3. STJ shares were up 7.1% last week, and they are up 20.3% YTD, after the company reported its Q4 report on Wednesday, beating analyst revenue and earnings estimates. The shares currently trade at 11-12 forward P/E and 2.9 P/B compared to averages of 29.3 and 3.9 for its peers in the medical products group.

Jazz Pharmaceuticals (NASDAQ:JAZZ): JAZZ develops specialty drugs to treat unmet medical needs in neurology and psychiatry. On Friday, global private equity firm and LBO-specialist KKR Fund Holdings filed SEC Form SC 13D indicating that it holds 10.54 million or 19.2% of outstanding shares, an increase of 0.63 million shares from the 9.91 million shares it reported at the end of Q3. Besides KKR, life sciences venture capital firm Menlo Pak, CA-based Longitude Capital Partners also filed SEC Form SC 13D on Friday, indicating that it holds 3.89 million shares.

JAZZ shares trade at 11-12 forward P/E and 13.9 P/B compared to averages of 33.2 and 6.1 for its peers in the medical drugs group, while earnings are projected to rocket up from the current $2.98 on a TTM basis to $4.17 in 2017. We wrote about JAZZ in mid- to late-October after the company received an FDA warning letter citing multiple safety violations, opining in that piece that we viewed the sell-off as creating an opportunity to buy into this high-growth stock at discount prices, and recommended accumulating if prices fell into the low- to mid-$30s; since that recommendation, shares have risen over 25% in the past nine weeks.

Bank of New York Mellon Corp. (NYSE:BK): BK is a financial services company offering asset management, wealth management, asset servicing, issuer servicing, clearing services, and treasury services worldwide in 35 countries. On Friday, Boston-based Massachusetts Financial Services, with over $80 billion in 13-F assets per their latest Q3 filing, filed SEC Form SC 13G/A indicating that it holds 67.9 million or 5.6% of outstanding shares, an increase of 5.5 million shares from the 62.4 million shares it held at the end of Q3. BK trades at a discount 8 forward P/E and 0.7 P/B compared to averages of 9.6 and 0.7 for the major regional banks group.

Lam Research Corp. (NASDAQ:LRCX): LRCX designs, manufactures, refurbishes and services semiconductor processing equipments used in the fabrication of integrated circuits. It is a market leader in plasma etch and a leading supplier of single-wafer clean products. On Friday, JPMorgan Chase & Co. filed SEC Form SC 13G/A indicating that it holds 10.7 million or 8.9% of outstanding shares, an increase of 1.7 million shares from the 9.0 million shares it held at the end of Q3. LRCX trades at a current 12.1 P/E on a TTM basis and 2.2 P/B compared to averages of 9.6 and 2.6 for its peers in the semiconductor equipment wafer fabrication group.

Accenture Plc (NYSE:ACN): ACN provides management consulting, and technology and outsourcing services to businesses and government agencies. On Friday, Boston-based Massachusetts Financial Services, with over $80 billion in 13-F assets per their latest Q3 filing, filed SEC Form SC 13G/A indicating that it holds 35.9 million or 5.5% of outstanding shares, an increase of 2.8 million shares from the 33.1 million shares it held at the end of Q3. ACN trades at a current 15.9 P/E on a TTM basis, and at 9.7 P/B, compared to averages of 16.6 and 1.6 for its peers in the consulting group.

On top of these, institutions filed 13D/G forms on other major stocks including US Airways Group (LCC), where Manning & Napier Advisors filed SEC Form SC 13G indicating that it hold 8.4 million or 5.2% of outstanding shares; wireless services provider NII Holdings Inc. (NASDAQ:NIHD), where Norges Bank filed SEC Form SC 13G/A that it holds 8.2 million or 4.8% of outstanding shares; A123 Systems Inc. (AONE), a manufacturer of rechargeable lithium-ion batteries and battery systems, where Capital Ventures International filed SEC Form SC 13G indicating that it holds 12.5 million shares; Brandywine Realty Trust (NYSE:BDN), an office and industrial properties REIT, where Vanguard Specialized Funds filed SEC Form SC 13G/A indicating that it holds 7.5 million or 5.5% of outstanding shares; Biomed Realty Trust Inc. (NYSE:BMR), a REIT that focuses on providing real estate to the life science industry in the U.S., where Vanguard Specialty Funds filed SEC Form SC 13G/A indicating that it holds 8.5 million or 5.5% of outstanding shares; leading biotech company Biogen Idec Inc. (NASDAQ:BIIB), where Vanguard Chester Funds filed SEC Form SC 13G/A indicating that it holds 12.1 million or 5.0% of outstanding shares; Kimco Realty Corp. (NYSE:KIM), a REIT that focuses on neighborhood and community shopping centers, where Vanguard Specialized Funds filed SEC Form SC 13G/A indicating that it holds 22.6 million or 5.5% of outstanding shares; Host Hotel & Resorts Inc. (NYSE:HST), a REIT that focuses primarily on luxury and upper upscale hotels, where Vanguard Specialized Funds filed SEC Form SC 13G/A indicating that it holds 39.1 million or 5.5% of outstanding shares; and Westport Innovations Inc. (NASDAQ:WPRT), a manufacturer of high-performance, low-emission engines and fuel injection systems that use natural gas, LPG and biogas, where Manning & Napier Advisors filed SEC Form SC 13G indicating that it holds 3.4 million or 7.0% of outstanding shares.

Credit: Fundamental data in this article were based on SEC filings, I-Metrix® by Edgar Online®, Zacks Investment Research, Thomson Reuters and Briefing.com. The information and data is believed to be accurate, but no guarantees or representations are made.

Disclaimer: Material presented here is for informational purposes only. Nothing in this article should be taken as a solicitation to purchase or sell securities. Before buying or selling any stock you should do your own research and reach your own conclusion. Further, these are our 'opinions' and we may be wrong. We may have positions in securities mentioned in this article. You should take this into consideration before acting on any advice given in this article. If this makes you uncomfortable, then do not listen to our thoughts and opinions. The contents of this article do not take into consideration your individual investment objectives so consult with your own financial adviser before making an investment decision. Investing includes certain risks including loss of principal.

Source: Friday's Noteworthy Institutional 5% Ownership Filings